New, Larger Cancer Center Opens in mid-March; Community Invited to Open House on March 7
Mountain View, CA - March 2, 2015- El Camino Hospital today announced that its new, expanded Cancer Center will open in Oak Pavilion in mid-March. The $5.5 million expansion makes advanced cancer treatments and therapies available to more patients and is designed with patients and their families in mind.
Mountain View, CA - November 21, 2014 – El Camino Hospital announced today that it is the first hospital in Northern California to adopt the use of the Niveus Medical Muscle Stimulation System 110, a thermal-enhanced electrical muscle stimulation intervention implemented to prevent hospital-acquired weakness in patients. This new technology is being used in the critical care of the hospital to enhance other initiatives taken by the hospital to minimize the impact of weakness on patient recovery, including early mobility and ambulation programs and dedicated patient rehabilitation teams for the critical care unit.
Mountain View, CA - November 17, 2014 - A new effort launching today could help turn ordinary Mountain View residents into life-saving heroes. By installing automated external defibrillators (AEDs) at high-risk locations throughout the city, the program aims to reduce deaths from sudden cardiac arrest.
"Sudden cardiac arrest is a killer, but it doesn't have to be," said Santa Clara County Supervisor Joe Simitian, whose district includes Mountain View. "These 21st-century AED's are as close to foolproof as anything can be, and blanketing the community with them really can save lives."
Mountain View, CA - November 7, 2014 - El Camino Hospital Foundation received a $1 million gift from Los Altos philanthropists Donna and John Shoemaker for the expansion of El Camino Hospital’s mental health services.
Mountain View, Calif. – October 31, 2014 – El Camino Hospital is the first facility in South Bay area to implant the Nanostim™ leadless pacemaker, the world’s first retrievable, non-surgical pacing technology, as part of the LEADLESS II Clinical Trial. Developed for patients with bradycardia – a heart rate that is too slow – the Nanostim device is designed to be placed directly in a patient’s heart without the visible lump, scar and insulated wires (called leads) required for conventional pacemakers.